Tirzepatide 20mg

Description

CAS Number: 2023788-19-2

Disclaimer:

For research use only. Not for human consumption. Intended for laboratory-based studies by qualified professionals. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.

Overview:
Tirzepatide is a dual incretin mimetic peptide studied for its potent effects on metabolic regulation, appetite suppression, and insulin sensitivity. It acts as a dual agonist at both the GLP-1 and GIP receptors, offering a next-generation approach to weight management and glycemic control in metabolic research models.

Mechanism of Action:

• GLP-1 receptor activation promotes insulin secretion, reduces glucagon output, delays gastric emptying, and increases satiety through central nervous system signaling.
• GIP receptor activation enhances glucose-dependent insulin release and supports lipid metabolism and energy utilization.

Specifications:
Form: Lyophilized powder (research-grade)
Purity: ≥98% (HPLC-tested)
Storage: Store refrigerated (2–8°C), protected from light and humidity.

For research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.